Maria Del Valle Estopinal

Dr. Maria Del Valle Estopinal

Department of Ophthalmology and Pathology, University of California, Irvine, CA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2020 in Case Reports in Pathology
Verified
Journal Article
Open access
PDF file
VNVamsee K. Neerukonda
Vamsee K. Neerukonda
BCBryant Carruth
Bryant Carruth
MEMaria Del Valle Estopinal
Maria Del Valle Estopinal
Lacrimal gland neoplasms comprise up to 18% of all orbital masses clinically and histologically. Much of our current core knowledge regarding lacrimal gland tumors stems from prior study of their more common counterparts, the salivary glands. The prognosis for each lacrimal gland tumor is contingent upon proper clinical evaluation and ultimately the histopathologic diagnosis. We describe a case of an invasive carcinoma ex-pleomorphic adenoma (Ca-ex-PA) with a cystadenocarcinoma component arising from the lacrimal gland in the absence of any previously diagnosed pleomorphic adenoma (benign mixed tumor) or prior incisional surgery. This case illustrates the importance of the histopathologic assessment including immunohistochemistry and genetic testing to narrow a differential diagnosis and potentially aid or guide therapy in the future. Our finding suggests that carcinoma of the lacrimal gland may be derived from previously undiagnosed and perhaps even subclinical pleomorphic adenoma.

14 July 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MEMaria Del Valle Estopinal
Maria Del Valle Estopinal
RSRobert Swan
Robert Swan
KRKevin Rosenberg
Kevin Rosenberg
We report a case of a 74-year-old gentleman who presented with floaters and decreased vision in the right eye after cataract surgery. His past medical history was significant for metastatic renal cell carcinoma (mRCC) to bone, lung and abdomen which was presumed stable for the last two years while on the tyrosine kinase inhibitor (TKI), pazopanib. Clinical examination revealed significant vitritis with a distinctive clumping of cells on the pre-retinal surface and posterior hyaloid face. Magnetic resonance imaging of the brain revealed new lesions suspicious for metastases. A diagnostic vitrectomy was performed to determine the nature of the vitritis and clear the visual axis. Cytopathologic evaluation of the vitreous demonstrated clusters of malignant cells that were positive for AE1/AE3 and PAX-8, and negative for the CD20, CD3, RCC, SOX-10 and S-100 immunohistochemical markers. The overall findings favored a metastatic RCC to the vitreous. Choroidal and retinal metastases from mRCC have been previously reported; however, vitreous involvement by mRCC with no evidence of retinal or choroidal mass has not been described. New treatments of mRCC include TKIs which target vascular endothelial growth factor receptors (VEGFRs). Herein, we analyze the factors that could have precipitated this unusual metastasis to the vitreous.

11 November 2021 in Case Reports in Pathology
Verified
Journal Article
Open access
PDF file
MEMaria Del Valle Estopinal
Maria Del Valle Estopinal
LMLavinia P. Middleton
Lavinia P. Middleton
BEBita Esmaeli
Bita Esmaeli
KPKeyur P. Patel
Keyur P. Patel
SNSara Nowroozizadeh
Sara Nowroozizadeh
MWMichelle D. Williams
Michelle D. Williams
Signet Ring Cell (SRC)/Histiocytoid carcinoma of the eyelid is a rare neoplasm that shares histological and immunohistochemical similarities with diffuse gastric cancer and breast lobular carcinoma. The CDH1 gene, which encodes the E-cadherin protein, is the best known gene associated with these tumors. The structural and functional integrity of E-cadherin is regulated by interconnecting molecular pathways which might participate in the development of this disease. Hence, we analyzed the protein expression in key genes in E-cadherin-related pathways associated with primary SRC/Histiocytoid carcinoma of the eyelid. SRC/Histiocytoid carcinoma diagnosed in the eyelid/orbit at MD Anderson Cancer Center from 1990 to 2016 were evaluated. Clinicopathologic findings were studied to confirm the primary site of origin. Immunohistochemical studies for the expression of E-cadherin, β-catenin, c-Myc, Cyclin D1, Src, and p53 were analyzed. Next generation sequencing for the detection of somatic mutations was performed on each tumor with matched normal tissue, examining 50 cancer-related genes. Four primary SRC/Histiocytoid carcinomas of the eyelid were diagnosed in four male patients aged 40-82 years. Immunohistochemically, two tumors with loss of E-cadherin expression had weak β-catenin and low cytoplasmic staining for Src while the other two cases with intact E-cadherin showed strong β-catenin expression and high cytoplasmic expression for Src. Cyclin D1 was focally positive in three cases. Somatic mutations in CDH1, PIK3CA, and TP53 genes were detected in two cases. Our results suggest an abnormality in the convergence of E-cadherin/β-catenin pathways which may promote tumorigenesis by inducing expression of oncogenes such as Cyclin D1 and C-Myc. Mutations in CDH1, PIK3CA, and TP53 genes could induce E-cadherin dysfunction which takes part in the development and progression of this malignancy.

19 May 2026 in Cornea
Verified
Journal Article
Closed access
DMDavid M. Morcos
David M. Morcos
BCBlaze A. Carbonell
Blaze A. Carbonell
NRNikhith Rao
Nikhith Rao
MKMelisa Karslioglu
Melisa Karslioglu
JFJosé A. P. M. Filho
José A. P. M. Filho
OLOlivia L. Lee
Olivia L. Lee
Purpose: To describe the risk factors, clinical course, and characteristics of 5 cases of acute calcific band keratopathy (BK) after the use of recombinant human nerve growth factor for neurotrophic keratitis. Methods: A single-center retrospective chart review of 43 eyes of 43 patients previously diagnosed with neurotrophic keratitis from April 2021 to October 2023 was conducted. All patients had previously completed at least one 8-week course of topical cenegermin 0.002%. Five of the 43 cenegermin-treated eyes that developed BK are included in this series. Results: The incidence of BK was 11.6%. The median time from treatment initiation to BK was 8 weeks. A corneal biopsy confirmed the presence of calcification in 2 cases. All 5 patients had persistent calcium deposits after discontinuing treatment. Prolonged epithelial defect healing time while on treatment was observed in patients who developed BK. Conclusions: BK was observed after cenegermin use. Herein, we report a series of 5 cases, which occurred at the same institution. Ethylenediaminetetraacetic acid chelation therapy had variable results, with 4 out of 5 patients requiring repeated surgical intervention because of multiple recurrences of BK.

20 March 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
TSTara Shooshani
Tara Shooshani
MHMichael Myung-sup Han
Michael Myung-sup Han
JTJeremiah P. Tao
Jeremiah P. Tao
SSSamuel J. Spiegel
Samuel J. Spiegel
MEMaria Del Valle Estopinal
Maria Del Valle Estopinal
Neurolymphomatosis (NL) is a rare manifestation of hematologic malignancies, characterized by a neoplastic infiltration of the peripheral nervous system and cranial nerves (CNs). Non-Hodgkin lymphomas (NHLs) account for 90% of NL cases, while acute leukemia represents 10% of the cases. NL can occur as the first manifestation of a malignancy (primary), or as a relapse or progression of a previously treated disease (secondary). Herein, we report a unique case of NL involving the left orbit and CNs in a 74-year-old female with primary central nervous system (CNS) diffuse large B-cell lymphoma (DLBCL). Our patient developed secondary neurolymphomatosis involving the left orbit and CNs II, III, V, and VI, supported by clinical, radiologic, and histologic findings. The lacrimal gland enhancement was histopathologically proven to be caused by the direct spread of CNS DLBCL to the lacrimal nerve, a branch of CN V, identifying NL as one of the conditions that can affect this organ. The lacrimal gland could be considered as a more accessible biopsy site when the involvement of CN V is suspected.

9 February 2023 in Case Reports in Pathology
Verified
Journal Article
Open access
PDF file
SZSherehan Zada
Sherehan Zada
JTJeremiah Tao
Jeremiah Tao
MEMaria Del Valle Estopinal
Maria Del Valle Estopinal
Signet-ring cell squamous cell carcinoma (SRCSCC) is an uncommon variant of cutaneous SCC that has been reported in the head and neck region. Herein, we present a case of a 56-year-old female with a cutaneous SCC that recurred after surgical excision, during treatment with cemiplimab (a programmed death receptor-1 (PD-1) inhibitor). Histologically, the recurrent SCC revealed a second component characterized by the presence of signet-ring-like cells (SRLCs). Immunohistochemical studies demonstrated that the tumor cells were positive for P63, CK5/6, CDX2, and P53 while negative for P16, CK7, CK20, and CD68 stains. An abnormal expression of B-catenin was also observed in the tumor. To our knowledge, SRCSCC developing during treatment with an immune checkpoint inhibitor has not been documented in the literature. Our findings suggest a form of acquired SCC cell resistance to immunotherapy that might involve CDX2-related pathways.